STOCKHOLM, Sweden, Nov. 21, 2013 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) has been awarded Best Biotech Pipeline at the World Orphan Drug Congress in Geneva. The award recognises the size and range of Sobi's orphan pipeline and also the mix across designation and authorisation phases within the portfolio. The judging panel also acknowledged Sobi's long-term future as well as the company's pioneering development approach and commitment to the rare disease and orphan drug space.
Help employers find you! Check out all the jobs and post your resume.
